increases

reporting period from €312,9m to € 372,1m. This increase was principally due to the acquisition of the AXA portfolio in October 2022 where a capital injection of €50m was carried out. The SCR increased from € 127,4m to € 147,7m over the reporting period. This change is also principally due to the aforementioned acquisition and subsequent reinsurance applicable on the whole balance sheet of the Company. The absolute MCR of € 66.5m increases by €9,2m compared to year-end 2021. The solvency ratio of

% Ratio of Own Funds to MCR 841% 560% Eligible Own funds increased significantly over the reporting period from €372,1m to € 386,4m. The SCR decreased from € 147,7m to € 102,1m over the reporting period. This decrease can be explained on the one hand by... decreased in line with the SCR from € 66,5m to €45,9m compared to the year-end 2022. The solvency ratio of the Company increased from 252% to 378% over the reporting period. Further details of the Company’s Own Funds and SCR are provided in Section E